The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Parmar Kush since year 2005.
The trader's CIK number is 1664281.
At the time of the last reporting, Parmar Kush was the 10% Owner of Aprea Therapeutics, Inc. .
(stock ticker symbol APRE).
See this page for all insider trading activities at Aprea Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-07||APRE||Aprea Therapeutics, Inc.||Buy||333,333||15.00||4,999,995|
|2019-05-16||FIXX||Homology Medicines, Inc.||Sale||615,000||21.47||13,204,050|
|2018-12-10||FIXX||Homology Medicines, Inc.||Sale||15,575||26.00||405,027|
|2018-11-23||FIXX||Homology Medicines, Inc.||Sale||29,682||20.04||594,708|
|2018-11-16||FIXX||Homology Medicines, Inc.||Sale||525,900||20.20||10,623,180|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parmar Kush (10% Owner of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.